Results from a phase 2 randomized, placebo-controlled trial of liraglutide (1.23.0 mg) in 564 obese non-diabetic adults demonstrated that liraglutide 3.0 mg was statistically significantly more effective than orlistat, or diet and exercise alone, at reducing weight over 20 and 52 weeks, and weight loss was dose-dependent
"The present studies are only from a small number of individuals, and while the findings do raise concerns, it will be important that other approaches are now used in a larger group of living individuals to further investigate these findings," he said
10.1080/1040841X.2017.1303660 Crit
You Dont Have to Navigate Menopause Weight Gain Alone Menopause can change how your body processes food, stores fat, and may respond to traditional weight loss methods
GLP-1 agonists like Wegovy, Ozempic, and Mounjaro, which are used to treat type 2 diabetes and obesity, have been growing in popularity so much so that in December 2025, the Food and Drug Administration (FDA) approved an oral pill form of Wegovy for weight loss
Some advanced users use IGF-1 LR3 in the morning for systemic support and IGF-1 DES post-workout in trained muscles for targeted hypertrophy